Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications

13Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cysteinyl cathepsins (CTSs) are widely known to have a proteolysis function that mediates recycling of unwanted proteins in endosomes and lysosomes, and investigation of CTSs has greatly improved with advances in live-imaging techniques both in vivo and in vitro, leading to three key findings. (1) CTSs are relocated from the lysosomes to other cellular spaces (i.e., cytosol, nucleus, nuclear membrane, plasma membrane, and extracellular milieu). (2) In addition to acidic cellular compartments, CTSs also exert biological activity in neutral environments. (3) CTSs also exert multiple nontraditional functions in, for example, extracellular matrix metabolism, cell signaling transduction, protein processing/trafficking, and cellular events. Various stimuli regulate the expression and activities of CTSs in vivo and vitro—e.g., inflammatory cytokines, oxidative stress, neurohormones, and growth factors. Accumulating evidence has confirmed the participation of CTSs in vascular diseases characterized by atherosclerosis, plaque rupture, thrombosis, calcification, aneurysm, restenosis/in-stent-restenosis, and neovasel formation. Circulating and tissue CTSs are promising as biomarkers and as a diagnostic imaging tool in patients with atherosclerosis-based cardiovascular disease (ACVD), and pharmacological interventions with their specific and non-specific inhibitors, and cardiovascular drugs might have potential for the therapeutic targeting of CTSs in animals. This review focuses on the update findings on CTS biology and the involvement of CTSs in the initiation and progression of ACVD and discusses the potential use of CTSs as biomarkers and small-molecule targets to prevent deleterious nontraditional functions in ACVD.

References Powered by Scopus

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

3151Citations
N/AReaders
Get full text

Cysteine cathepsins: From structure, function and regulation to new frontiers

1025Citations
N/AReaders
Get full text

Plasma membrane repair is mediated by Ca<sup>2+</sup>-regulated exocytosis of lysosomes

822Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Vascular calcification and cellular signaling pathways as potential therapeutic targets

13Citations
N/AReaders
Get full text

Cathepsin B in cardiovascular disease: Underlying mechanisms and therapeutic strategies

3Citations
N/AReaders
Get full text

Cathepsin K deficiency prevented stress-related thrombosis in a mouse FeCl<inf>3</inf> model

3Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cheng, X. W., Narisawa, M., Wang, H., & Piao, L. (2023, December 1). Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications. Cell and Bioscience. BioMed Central Ltd. https://doi.org/10.1186/s13578-023-01040-4

Readers' Seniority

Tooltip

Researcher 2

67%

PhD / Post grad / Masters / Doc 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

50%

Biochemistry, Genetics and Molecular Bi... 2

50%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free